The global women’s health supplement market size is expected to reach a valuation of US$ 1,42,645.6 million by the end of 2023. It is further projected to expand at a CAGR of 7.5% in the estimated period 2024 to 2034. The market is anticipated to attain a valuation of around US$ 2,94,014.8 million in 2034 from US$ 1,52,169.9 million in 2024.
One thing is certain: the healthcare sector is ever-evolving. Policy adjustments by government agencies, astonishing research work, and constant innovations in technology all affect the field of healthcare.
In the ever-changing healthcare sector, another term has become quite common: health supplement, specifically for women. As awareness rises, so does the demand for health supplements, as women are looking at these to enhance their overall health.
As the population ages worldwide, several women are increasingly entering menopause and perimenopause. In developing countries where there can be a lack of knowledge of health and wellness, women often perceive symptoms of menopause, such as disrupted sleep and hot flashes, to be mystifying. Hence, healthcare professionals visiting rural areas have also started recommending health supplements for women.
When a woman goes through menopause or perimenopause, it sometimes takes longer than usual to recover from joint pain or lingering muscle after exercise. This can become a grave problem for several women. Changes in the levels of hormones can lead to such issues, and health supplements are expected to help in battling inflammation & pain.
Keeping menopause or perimenopause aside, the rat race to have glowing and dewy skin is anticipated to propel women’s health supplement sales. As a person age, they are often exposed to harsh environmental elements and the sun.
In such instances, lotions and creams are not enough to achieve the celebrity-inspired dewy skin. Several companies are coming up with new women-specific supplements infused with organic ingredients to help them prevent wrinkles, fine lines, and dry skin.
Attributes | Key Insights |
---|---|
Women’s Health Supplement Market Anticipated Value (2023A) | US$ 1,42,645.6 million |
Estimated Women’s Health Supplement Market Size (2024E) | US$ 1,52,169.9 million |
Projected Women’s Health Supplement Market Valuation (2034) | US$ 2,94,014.8 million |
Value-based CAGR (2024 to 2034) | 7.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global women’s health supplement market exhibited a CAGR of around 6.1% in the historical period from 2019 to 2023. The market for female wellness supplements is anticipated to showcase a CAGR of 7.5% in the assessment period. It stood at a valuation of US$ 1,12,132.6 million in 2019.
Historical CAGR (2019 to 2023) | 6.1% |
---|---|
Historical Value (2019) | US$ 1,12,132.6 million |
It appears that women's well-being and health are more important than ever these days, both in the media and in medical care. However, attention has not always been focused on women's healthcare needs and trends. In reality, it has been only in the last century and a half that medical professionals have realized how important it is to pay attention to the unique health needs of around 50% of the population.
Within the broader women's rights movement, the campaign for women's health gained traction in the 1960s and 1970s. Women battled for improved health care at the same time as they did for equal rights, salary, and a pathway to higher education. From early years through pregnancy & postpartum care and beyond menopause, women started to seek better services to satisfy their requirements.
To encourage more study on the trends and issues pertaining to women's health, the National Institutes of Health (NIH) founded the Office of Research on Women's Health in 1990. The organization started a 14-year allocated control experiment called the Women's Health Initiative by investing US$ 625 million in 1992. It aimed to educate women about osteoporosis, cancer, and cardiovascular disease prevention.
As awareness increased among minority women, government bodies across several countries started initiatives such as the National Asian Women's Health Organization, the Black Women's Health Imperative, the Native American Women's Health Education and Resource Center, and more. The increasing number of clinics and healthcare facilities globally is anticipated to push the need for better care for women, thereby augmenting health supplement demand.
The section below highlights the CAGRs of the leading countries in the women’s health supplement market. The three main countries in the countries include India, the United Kingdom, and China.
According to the analysis, India is set to lead the women’s health supplement market by showcasing a CAGR of 8.5% in the forecast period. The country is anticipated to be followed by the United Kingdom and China, with CAGRs of 6.3% and 6.2%, respectively.
Countries | Value-based CAGR (2024 to 2034) |
---|---|
United States | 5.5% |
India | 8.5% |
China | 6.2% |
United Kingdom | 6.3% |
Japan | 5.8% |
The United States is anticipated to showcase a steady CAGR of around 5.5% in the forecast period. The country is projected to hold around 29.4% of the women’s health food & supplement market share in 2034.
The growing participation of women in several sports activities and the surging population of senior citizens are expected to drive demand in the United States. The rising shift of modern women toward self-directed care is also anticipated to bolster demand.
The increasing focus of women on preventive healthcare has led to the surging consumption of health supplements and declining sales of prescription pharmaceuticals. As not many health insurance firms cover the cost of medicines, individuals are moving toward health supplements to prevent chronic illnesses.
MegaFood, a United States-based supplement brand, for instance, introduced a new line of supplements called Women's Ensemble in May 2023 to celebrate Women's Health Month. The range contains Mood Reset & PMS Support and aims to enhance women’s mood and hormonal balance.
India’s women’s health supplement market is anticipated to exhibit a CAGR of around 8.5% from 2024 to 2034. The country is projected to hold a share of 8.7% in 2034.
Sales of beauty supplements are growing exponentially across India owing to the increasing influence of social media platforms, celebrity endorsements by leading brands, and the e-commerce boom. Consumer confidence in beauty supplements is augmenting due to the investment of brands in research work to support the efficacy of certain ingredients.
In July 2023, for instance, Oriflame India introduced two latest health supplements under its Wellosophy line. These were developed mainly for women and include magnesium, vitamin D, and calcium. These regular supplements provide hectic schedules an extra push and encourage an active, healthy lifestyle.
The women’s beauty supplement market in China is projected to hold a share of around 9.1% in 2034. It will likely exhibit a steady CAGR of 6.2% in the assessment period.
The skyrocketing demand for prenatal vitamin supplements in China is expected to drive the market forward. Gynecologists are now recommending prenatal health supplements to lower the risk of birth defects and support healthy development.
Feminine health products, such as prenatal health supplements, are further gaining traction with the presence of several NGOs in China offering these for free. They aim to improve the health conditions of pregnant women in remote areas and prevent conditions such as micronutrient deficiencies.
The United Kingdom’s female wellness supplement industry outlook predicts that demand will expand considerably in the forecast years. The country is projected to account for a decent share of 4.3% in 2034.
Renowned brands in the United Kingdom are investing extensively in research & development activities to discover new ingredients. They have started using berberine and creatine in women’s health supplements to help maintain high cholesterol PCOS, and boost muscle mass.
As per the National Health Service (NHS), polycystic ovary syndrome (PCOS) affects about 1 in every 10 women in the United Kingdom. However, half of these women do not exhibit any symptoms at all.
With the increasing prevalence of PCOS in the United Kingdom, companies are looking for novel ingredients to include in their in-house supplements. They have recently found curcumin to be an organic medicine for the condition. Hence, the launch of innovative health supplements in the country to battle PCOS is set to aid demand.
The women-specific supplement market growth in Japan is set to remain considerable throughout the estimated period. The rising trend for surrogacy in the country is expected to propel the demand for prenatal and postnatal health supplements.
Japan is anticipated to hold a share of about 6.3% in 2034. The growth will be further pushed by the increasing focus of women on their cognitive and mental health.
Over the past couple of decades, a lot of women have observed a noticeable increase in their depression and anxiety levels, which have been made worse by problems such as the global pandemic. A portion of these depressive and anxious symptoms were directly related to COVID-19.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The tables below showcase the growth rates of leading segments in the women’s health supplement market. In terms of type, the vitamins & minerals segment will likely witness a CAGR of 8.7% in the estimated period. Based on dosage form, the capsule segment is set to exhibit a CAGR of 9.0% from 2024 to 2034.
By Type | Value-based CAGR (2024 to 2034) |
---|---|
Vitamins & Minerals | 8.7% |
Proteins | 6.7% |
Amino Acids | 5.8% |
Other Nutritional Substances | 7.3% |
Based on type, the vitamins & minerals segment is expected to dominate the global women’s health supplement market through 2034. It is set to witness a CAGR of 8.7% from 2024 to 2034.
Women mainly prefer supplements infused with essential vitamins & minerals to prevent nutrient deficiencies. These supplements have proved to be a convenient method of providing individuals with important vitamins & minerals that are often absent in their diet.
In June 2023, for instance, VÖOST introduced VÖOST Gummies to broaden its range of supplements. The tasty, fruit-based vitamins satisfy consumers' constantly changing needs for health & wellness and offer a delightful texture without any added sugar.
By Dosage Form | Value-based CAGR (2024 to 2034) |
---|---|
Tablets | 8.4% |
Capsules | 9.0% |
Powders | 5.4% |
Liquids | 4.1% |
In terms of dosage form, the capsule segment is expected to showcase a CAGR of 9.0% in the forecast period. This growth is attributed to the ability of capsules to offer precise dosage. These enable consistent and accurate intake of health supplements without causing an overdose.
The growing shift of modern women toward vegan or vegetarian diets is another significant factor accelerating demand. Women's dietary supplements in the form of capsules can be a suitable alternative for those following such diets.
In March 2022, Vestige Marketing, based in New Delhi, introduced Vestige Her Own Capsules to cater to the nutritional needs of women. As per the company, the new capsules can help enhance women’s well-being, lower mood swings, and prevent tiredness during PMS.
With several competitors in the women’s health supplement-manufacturing sphere, the overall market has multiple manufacturers and suppliers. To meet consumer demand and expand their customer base, these companies are implementing strategies such as mergers & acquisitions, partnerships & collaborations, and new product launches.
Key Developments by Leading Players in Women’s Health Supplement Market
Attribute | Details |
---|---|
Estimated Women’s Health Supplement Market Value (2024) | US$ 1,52,169.9 million |
Projected Women’s Health Supplement Market Value (2034) | US$ 2,94,014.8 million |
Expected Growth Rate (2024 to 2034) | 7.5% |
Forecast Period | 2019 to 2023 |
Historical Data Available for | 2024 to 2034 |
Market Analysis | US$ million for Value |
Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC, and South Africa |
Key Market Segments Covered | Type, Dosage Form, Distribution Channel, and Region |
Key Companies Profiled | Abbott; Vitabiotics Ltd.; Herbalife Nutrition; Natural Health Concept; GNC Holdings; Biocyte Laboratory; Amway; NOW Health; AdvoCare; Nature's Bounty; Banyan Botanicals; Source Naturals; Nature's Way Products; Nutramarks Inc.; Natural Immunogenics; Nutramax Laboratories; Solaray Inc.; Sambucol USA; Quantum Health, Inc.; Rainbow Light; Pure Encapsulations, LLC.; Country Life, LLC; INFINITUS; Real Nutriceutical; Southernature |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The women's health supplement market is set to reach US$ 2,94,014.8 million by 2034.
The women’s health supplements market was valued at US$ 1,42,645.6 million in 2023.
Abbott, Herbalife Nutrition, Amway, and NOW Health.
Vitamin D, probiotics, multivitamins, and calcium-based supplements.
Women’s health supplements in the dosage form of capsules are the best.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Market Round Offs 1.5. Future Market Insights (FMI) Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Brand Mapping Analysis 3.1. Price v/s Type 3.2. Value for Money 3.3. Top of Mind Women’s Health Supplement Brands 3.4. Brand Portfolio-by Key Players 3.5. Brand Loyalty Mapping 3.6. Source Pattern Overview 3.7. Branded vs Unbranded-Market Mix 4. Distribution Channel Wise Key Brand Positioning 4.1. Global Top Retailers and their Brand Offerings 4.1.1. Hypermarkets/Supermarkets 4.1.2. Specialty Stores 4.1.3. Pharmacy & Drug Stores 4.1.4. Online Retail 4.2. Retail Pricing Strategies 5. Consumer Buying Behavior Analysis 5.1. Functionality and Type Demand 5.1.1. Vitamins & minerals 5.1.2. Proteins 5.1.3. Amino acids 5.1.4. Other nutritional substances 5.2. What factors do you consider when deciding to purchase Women’s Health Supplement? 5.3. How important are Type certifications when choosing Women’s Health Supplement? 5.4. How important is the brand reputation and recognition when selecting Women’s Health Supplement? 5.5. What marketing channels do you prefer for learning about new Women’s Health Supplement? 5.6. How often do you purchase new Women’s Health Supplement? 5.6.1. Once or More Every Month 5.6.2. Once Every 2 months 5.6.3. Once Every 6 Months 5.6.4. Once a Year 5.6.5. Less Than Once A Year 6. Market Trends & Dynamics 6.1. Per capita spending on Women’s Health Supplement 6.2. Key Trends Impacting the Market 6.3. Type Innovation / Development Trends 6.3.1. Latest Trends and Demands 6.3.2. Latest Innovations and New Launches 6.4. Future Prospects of Organic Cosmetics Industry 6.5. Market Dynamics 6.5.1. Drivers 6.5.2. Restraints 6.5.3. Opportunity Analysis 7. Value Added Insights 7.1. Type Adoption Analysis 7.2. Vitamin Deficiency Epidemiology 7.3. New Type Approvals/ Launches 7.4. Rise in Demand for Energy & Immunity Supplement 7.5. Regulatory Landscape 7.6. PESTEL Analysis 7.7. Porter’s Analysis 7.8. Value Chain Analysis 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Expenditure 8.1.3. Global Health Supplement Market Overview 8.2. Forecast Factors - Relevance & Impact 8.2.1. Top Companies Historical Growth 8.2.2. Pharmaceutical spending 8.2.3. Adoption of Women’s Health Supplement 8.2.4. Type & Stock Availability 8.2.5. Rise in number of Health Conscious Population 8.2.6. Companies Increasingly Spending on R&D and Focus on Innovation 8.2.7. Collaborations and Agreements between Manufacturers 9. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034 9.1. Historical Market Value (US$ million) Analysis, 2019 to 2023 9.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ million) Analysis By Type, 2019 to 2023 10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Type, 2024 to 2034 10.3.1. Vitamins & Minerals 10.3.2. Proteins 10.3.3. Amino Acids 10.3.4. Other Nutritional Substances 10.4. Market Attractiveness Analysis By Type 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ million) Analysis By Dosage Form, 2019 to 2023 11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Dosage Form, 2024 to 2034 11.3.1. Tablets 11.3.2. Capsules 11.3.3. Powders 11.3.4. Liquid 11.4. Market Attractiveness Analysis By Dosage Form 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ million) Analysis By Distribution Channel, 2019 to 2023 12.3. Current and Future Market Size (US$ million) Analysis and Forecast By Distribution Channel, 2024 to 2034 12.3.1. Hypermarkets/Supermarkets 12.3.2. Specialty Stores 12.3.3. Pharmacy & Drug Stores 12.3.4. Online Retail 12.4. Market Attractiveness Analysis By Distribution Channel 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 13.1. Introduction 13.2. Historical Market Size (US$ million) Analysis By Region, 2019 to 2023 13.3. Current and Future Market Size (US$ million) Analysis and Forecast By Region, 2024 to 2034 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East & Africa 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. United States 14.3.1.2. Canada 14.3.2. By Type 14.3.3. By Dosage Form 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Type 14.4.3. By Dosage Form 14.4.4. By Distribution Channel 14.5. Market Trends 14.6. Market Drivers & Restraints – Intensity Mapping 14.7. Country Level Analysis & Forecast 14.7.1. United States Market 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Type 14.7.1.2.2. By Dosage Form 14.7.1.2.3. By Distribution Channel 14.7.2. Canada Market 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Type 14.7.2.2.2. By Dosage Form 14.7.2.2.3. By Distribution Channel 15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of LATAM 15.3.2. By Type 15.3.3. By Dosage Form 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Type 15.4.3. By Dosage Form 15.4.4. By Distribution Channel 15.5. Market Trends 15.6. Market Drivers & Restraints – Intensity Mapping 15.7. Country Level Analysis & Forecast 15.7.1. Brazil Market 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Type 15.7.1.2.2. By Dosage Form 15.7.1.2.3. By Distribution Channel 15.7.2. Mexico Market 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Type 15.7.2.2.2. By Dosage Form 15.7.2.2.3. By Distribution Channel 15.7.3. Argentina Market 15.7.3.1. Introduction 15.7.3.2. Market Analysis and Forecast by Market Taxonomy 15.7.3.2.1. By Type 15.7.3.2.2. By Dosage Form 15.7.3.2.3. By Distribution Channel 16. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 16.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. United Kingdom 16.3.1.2. Germany 16.3.1.3. France 16.3.1.4. Italy 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Russia 16.3.1.8. Rest of Europe 16.3.2. By Type 16.3.3. By Dosage Form 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Type 16.4.3. By Dosage Form 16.4.4. By Distribution Channel 16.5. Market Trends 16.6. Market Drivers & Restraints – Intensity Mapping 16.7. Country Level Analysis & Forecast 16.7.1. United Kingdom Market 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Type 16.7.1.2.2. By Dosage Form 16.7.1.2.3. By Distribution Channel 16.7.2. Germany Market 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Type 16.7.2.2.2. By Dosage Form 16.7.2.2.3. By Distribution Channel 16.7.3. France Market 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Type 16.7.3.2.2. By Dosage Form 16.7.3.2.3. By Distribution Channel 16.7.4. Spain Market 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast by Market Taxonomy 16.7.4.2.1. By Type 16.7.4.2.2. By Dosage Form 16.7.4.2.3. By Distribution Channel 16.7.5. Italy Market 16.7.5.1. Introduction 16.7.5.2. Market Analysis and Forecast by Market Taxonomy 16.7.5.2.1. By Type 16.7.5.2.2. By Dosage Form 16.7.5.2.3. By Distribution Channel 16.7.6. BENELUX Market 16.7.6.1. Introduction 16.7.6.2. Market Analysis and Forecast by Market Taxonomy 16.7.6.2.1. By Type 16.7.6.2.2. By Dosage Form 16.7.6.2.3. By Distribution Channel 16.7.7. Russia Market 16.7.7.1. Introduction 16.7.7.2. Market Analysis and Forecast by Market Taxonomy 16.7.7.2.1. By Type 16.7.7.2.2. By Dosage Form 16.7.7.2.3. By Distribution Channel 17. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 17.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Type 17.3.3. By Dosage Form 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Type 17.4.3. By Dosage Form 17.4.4. By Distribution Channel 17.5. Market Trends 17.6. Market Drivers & Restraints – Intensity Mapping 17.7. Country Level Analysis & Forecast 17.7.1. China Market 17.7.1.1. Introduction 17.7.1.2. Market Analysis and Forecast by Market Taxonomy 17.7.1.2.1. By Type 17.7.1.2.2. By Dosage Form 17.7.1.2.3. By Distribution Channel 17.7.2. Japan Market 17.7.2.1. Introduction 17.7.2.2. Market Analysis and Forecast by Market Taxonomy 17.7.2.2.1. By Type 17.7.2.2.2. By Dosage Form 17.7.2.2.3. By Distribution Channel 17.7.3. South Korea Market 17.7.3.1. Introduction 17.7.3.2. Market Analysis and Forecast by Market Taxonomy 17.7.3.2.1. By Type 17.7.3.2.2. By Dosage Form 17.7.3.2.3. By Distribution Channel 18. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18.1. Introduction 18.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 18.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 18.3.1. By Country 18.3.1.1. India 18.3.1.2. Indonesia 18.3.1.3. Thailand 18.3.1.4. Malaysia 18.3.1.5. Rest of South Asia 18.3.2. By Type 18.3.3. By Dosage Form 18.3.4. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Type 18.4.3. By Dosage Form 18.4.4. By Distribution Channel 18.5. Market Trends 18.6. Market Drivers & Restraints – Intensity Mapping 18.7. Country Level Analysis & Forecast 18.7.1. India Market 18.7.1.1. Introduction 18.7.1.2. Market Analysis and Forecast by Market Taxonomy 18.7.1.2.1. By Type 18.7.1.2.2. By Dosage Form 18.7.1.2.3. By Distribution Channel 18.7.2. Indonesia Market 18.7.2.1. Introduction 18.7.2.2. Market Analysis and Forecast by Market Taxonomy 18.7.2.2.1. By Type 18.7.2.2.2. By Dosage Form 18.7.2.2.3. By Distribution Channel 18.7.3. Thailand Market 18.7.3.1. Introduction 18.7.3.2. Market Analysis and Forecast by Market Taxonomy 18.7.3.2.1. By Type 18.7.3.2.2. By Dosage Form 18.7.3.2.3. By Distribution Channel 18.7.4. Malaysia Market 18.7.4.1. Introduction 18.7.4.2. Market Analysis and Forecast by Market Taxonomy 18.7.4.2.1. By Type 18.7.4.2.2. By Dosage Form 18.7.4.2.3. By Distribution Channel 19. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034 19.1. Introduction 19.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 19.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Type 19.3.3. By Dosage Form 19.3.4. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Type 19.4.3. By Dosage Form 19.4.4. By Distribution Channel 19.5. Market Trends 19.6. Market Drivers & Restraints – Intensity Mapping 19.7. Country Level Analysis & Forecast 19.7.1. Australia Market 19.7.1.1. Introduction 19.7.1.2. Market Analysis and Forecast by Market Taxonomy 19.7.1.2.1. By Type 19.7.1.2.2. By Dosage Form 19.7.1.2.3. By Distribution Channel 19.7.2. New Zealand Market 19.7.2.1. Introduction 19.7.2.2. Market Analysis and Forecast by Market Taxonomy 19.7.2.2.1. By Type 19.7.2.2.2. By Dosage Form 19.7.2.2.3. By Distribution Channel 20. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 20.1. Introduction 20.2. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2019 to 2023 20.3. Current and Future Market Size (US$ million) Analysis and Forecast By Market Taxonomy, 2024 to 2034 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. South Africa 20.3.1.4. North Africa 20.3.1.5. Rest of MEA 20.3.2. By Type 20.3.3. By Dosage Form 20.3.4. By Distribution Channel 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Type 20.4.3. By Dosage Form 20.4.4. By Distribution Channel 20.5. Market Trends 20.6. Market Drivers & Restraints – Intensity Mapping 20.7. Country Level Analysis & Forecast 20.7.1. GCC Countries Market 20.7.1.1. Introduction 20.7.1.2. Market Analysis and Forecast by Market Taxonomy 20.7.1.2.1. By Type 20.7.1.2.2. By Dosage Form 20.7.1.2.3. By Distribution Channel 20.7.2. Türkiye Market 20.7.2.1. Introduction 20.7.2.2. Market Analysis and Forecast by Market Taxonomy 20.7.2.2.1. By Type 20.7.2.2.2. By Dosage Form 20.7.2.2.3. By Distribution Channel 20.7.3. South Africa Market 20.7.3.1. Introduction 20.7.3.2. Market Analysis and Forecast by Market Taxonomy 20.7.3.2.1. By Type 20.7.3.2.2. By Dosage Form 20.7.3.2.3. By Distribution Channel 20.7.4. North Africa Market 20.7.4.1. Introduction 20.7.4.2. Market Analysis and Forecast by Market Taxonomy 20.7.4.2.1. By Type 20.7.4.2.2. By Dosage Form 20.7.4.2.3. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Branding and Promotional Strategies, By Key Players 22.3. Key Development Analysis 22.4. Competition Deep Dive 22.4.1. Abbott Laboratories 22.4.1.1. Overview 22.4.1.2. Type Portfolio 22.4.1.3. Key Financials 22.4.1.4. Sales Footprint 22.4.1.5. Strategy Overview 22.4.2. Vitabiotics Ltd. 22.4.3. Herbalife Nutrition 22.4.4. Natural Health Concept 22.4.5. GNC Holdings 22.4.6. Biocyte Laboratory 22.4.7. Amway 22.4.8. NOW Health 22.4.9. AdvoCare 22.4.10. Nature's Bounty 22.4.11. Banyan Botanicals 22.4.12. Source Naturals 22.4.13. Nature's Way Products 22.4.14. Nutramarks Inc. 22.4.15. Natural Immunogenics 22.4.16. Nutramax Laboratories 22.4.17. Solaray Inc. 22.4.18. Sambucol USA 22.4.19. Quantum Health, Inc. 22.4.20. Rainbow Light 22.4.21. Pure Encapsulations, LLC. 22.4.22. Country Life, LLC 22.4.23. INFINITUS 22.4.24. Real Nutriceutical, Southernature 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports